This company listing is no longer active
Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
9 Meters Biopharma Bilanço Sağlığı
Finansal Sağlık kriter kontrolleri 0/6
9 Meters Biopharma has a total shareholder equity of $-6.3M and total debt of $5.1M, which brings its debt-to-equity ratio to -80.5%. Its total assets and total liabilities are $9.3M and $15.6M respectively.
Anahtar bilgiler
-80.5%
Borç/özkaynak oranı
US$5.07m
Borç
| Faiz karşılama oranı | n/a |
| Nakit | US$6.94m |
| Eşitlik | -US$6.30m |
| Toplam yükümlülükler | US$15.61m |
| Toplam varlıklar | US$9.31m |
Son finansal sağlık güncellemeleri
Recent updates
Finansal Durum Analizi
Kısa Vadeli Yükümlülükler: 2Q3A has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Uzun Vadeli Yükümlülükler: 2Q3A has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Borç-Özkaynak Tarihçesi ve Analizi
Borç Seviyesi: 2Q3A has negative shareholder equity, which is a more serious situation than a high debt level.
Borcun Azaltılması: 2Q3A's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Bilanço
Nakit Pist Analizi
Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.
İstikrarlı Nakit Pisti: 2Q3A has less than a year of cash runway based on its current free cash flow.
Tahmini Nakit Akışı: 2Q3A has less than a year of cash runway if free cash flow continues to reduce at historical rates of 27.4% each year